- Home
- GDEN vs CSTL Comparison
GDEN vs CSTL Comparison
Compare GDEN & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEN
- CSTL
- Stock Information
- Founded
- GDEN 1998
- CSTL 2007
- Country
- GDEN United States
- CSTL United States
- Employees
- GDEN N/A
- CSTL N/A
- Industry
- GDEN Services-Misc. Amusement & Recreation
- CSTL Medical Specialities
- Sector
- GDEN Consumer Discretionary
- CSTL Health Care
- Exchange
- GDEN Nasdaq
- CSTL Nasdaq
- Market Cap
- GDEN 642.7M
- CSTL 661.7M
- IPO Year
- GDEN 1999
- CSTL 2019
- Fundamental
- Price
- GDEN $20.11
- CSTL $31.63
- Analyst Decision
- GDEN Buy
- CSTL Strong Buy
- Analyst Count
- GDEN 6
- CSTL 6
- Target Price
- GDEN $32.33
- CSTL $38.33
- AVG Volume (30 Days)
- GDEN 223.4K
- CSTL 349.1K
- Earning Date
- GDEN 11-06-2025
- CSTL 11-03-2025
- Dividend Yield
- GDEN 4.95%
- CSTL N/A
- EPS Growth
- GDEN N/A
- CSTL N/A
- EPS
- GDEN 0.54
- CSTL N/A
- Revenue
- GDEN $649,900,000.00
- CSTL $343,530,000.00
- Revenue This Year
- GDEN N/A
- CSTL N/A
- Revenue Next Year
- GDEN $2.25
- CSTL N/A
- P/E Ratio
- GDEN $37.36
- CSTL N/A
- Revenue Growth
- GDEN N/A
- CSTL 10.15
- 52 Week Low
- GDEN $19.90
- CSTL $14.59
- 52 Week High
- GDEN $35.49
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- GDEN 27.64
- CSTL 82.58
- Support Level
- GDEN $19.90
- CSTL $23.31
- Resistance Level
- GDEN $22.73
- CSTL $24.64
- Average True Range (ATR)
- GDEN 0.59
- CSTL 1.31
- MACD
- GDEN -0.17
- CSTL 0.61
- Stochastic Oscillator
- GDEN 6.56
- CSTL 97.84
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.